Tenaya Therapeutics Inc. (TNYA)
TNYA trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.5210
-7.87% on the day
Market cap
$116.8M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | TNYA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001858848 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-12-12 |
| Latest annual report | 10-K | 2026-03-11 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-08-05 |
| Latest proxy | PRE 14A | 2026-10-13 |
Source: SEC EDGAR submissions feed, 349 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ARMP | Armata Pharmaceuticals Inc. | $3.10 | -14.60% | $115.3M |
| ENGN | enGene Therapeutics Inc. | $1.63 | -4.12% | $109.2M |
| LENZ | LENZ Therapeutics Inc. | $3.40 | -5.82% | $106.8M |
| ABOS | Acumen Pharmaceuticals Inc. | $1.81 | -10.15% | $131.3M |
| VYGR | Voyager Therapeutics Inc. | $2.15 | -5.29% | $132.5M |
| HUMA | Humacyte Inc. | $0.3589 | -7.88% | $99.7M |
| AVXL | Anavex Life Sciences Corp. | $1.48 | -1.99% | $137.2M |
| OTLK | Outlook Therapeutics Inc. | $0.5638 | -3.64% | $137.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier